Touch remains the only human sense that cannot be objectively measured or delivered remotely, creating a significant "Tangibility Gap" in digital healthcare. Plectrum bridges this gap by transforming tactile intervention into a quantifiable, clinical-grade digital modality.
Innovation
FABTIVE: The World’s First Active Fabric
Bi-directional Clinical Loop
A proprietary Active Fabric interface that delivers precise, software-controlled physical input directly to the skin. This AI-powered platform enables professional-grade Sensory Integration outside the clinic, providing real-time, adaptive regulation for individuals with ASD and SPD.
National Scalability
Bypassing traditional clinic bottlenecks by deploying a direct-to-payer virtual clinic model. This ensures rapid expansion and continuous care delivery across any patient population, regardless of physical infrastructure.
Objective Clinical Outcomes
Transforming subjective sensory experiences into actionable data, providing therapists and payers with measurable progress reports.
Closed-Loop AI Personalization
Synchronizing biometric response with automated regulation protocols to ensure the therapy is always precise and adaptive.
Continuous & Adaptive Sensory Integration
The Clinical Feedback Loop
Turning Subjective Experiences into Objective Clinical Outcomes
SENSE
Capture objective biometric and response data directly from the FABTIVE wearable
ANALYZE
Ai-driven algorithms formulate a personalized sensory regulation protocol in real time
RESPOND
Deliver targeted, sotware-controlled Active Tactile Intervention.
RECORD & LEARN
Automated CPT 97533 Documentation
A data-driven cycle designed to prevent sensory meltdowns and reduce acute healthcare costs.
Plectrum prototypes
Shirt
Full-torso deep pressure & regulation
up to 24 tactile points.
Protective Cap
Cranial sensory modulation for crisis prevention.
Sleeve
Targeted limb regulation for localized sensory input.
up to 24 tactile points.
Glove
High-definition tactile stimulation for fine motor support
Technical & Power Specifications
Connectivity: Low-latency Bluetooth communication for reliable, real-time remote commands.
Power Management: Sustained by a high-capacity rechargeable battery with a standard USB Type-C charging interface.
Operating Voltage: Precision-engineered for efficiency, operating between 3.5V and 5.2V DC (@1.2Amp MAX).
*. Images are for illustrative purposes only. Final product design may vary.
Adaptive Clinical Interface
The Plectrum software ecosystem provides a seamless bridge between clinical intent and physical intervention. Designed for cross-platform versatility, the application is fully optimized for Android and Windows OS, ensuring high-performance control across PCs, tablets, and mobile devices. For next-generation immersion, the platform features native XR (Extended Reality) integration, allowing haptic protocols to synchronize with virtual therapeutic environments.
Advanced User Interface (UI) & Oversight
Dynamic Programming: A fully flexible UI that grants therapists total control over vibration patterns, intensity, and spatial localization across up to 24 contact points.
Automated Reporting: The platform streamlines the administrative burden by generating comprehensive clinical reports and documentation, essential for evidence-based progress and insurance compliance.
*. Images are for illustrative purposes only. Final product design may vary.
A Blue Ocean Opportunity in Digital Health
The Business Case for Remote Sensory Integration
Market Size
$405M ARR Potential
Targeting 5,000 U.S. Pediatric OT Clinics.
Scalable B2B2C model leveraging existing provider networks
Unit Economics
$450 Monthly Revenue
Average billing per patient via Medicaid & Private Insurers.
High-margin 30% technology revenue share ($135 per patient/mo)
Compliance
CPT 97533 Ready
Optimized for Telehealth Modifier 95 reimbursement.
Registered as an FDA Class I: Therapeutic Vibrator (21 CFR 890.5975).
Fast-Track:
Enabling immediate market deployment by bypassing Class II 510(k) clearance delays. This streamlined regulatory path, combined with our scalable B2B2C model, ensures a rapid Time-to-Market (TTM) and sustainable growth through existing clinical networks.
Traction
Advanced R&D & IP Foundation
4 working prototypes integrated with SDK support for Android, Windows, and XR ecosystems
Strategic Clinical & Industrial Partnerships
LOI with Hadassah Medical Center for clinical validation; NDAs signed with industry leaders NILIT and Delta Galil
Patents filed and pending in the U.S., EU, and Israel
AI-Driven Adaptive Protocols developed in collaboration with IBM
Global Clinical Pilot Expansion (2026)
Recruiting leading institutions in the US, Israel, and Europe to validate remote sensory integration outcomes
Q1 2026
Graduated Hadassah/IBM Accelerator
Q2 2026
FDA Class I Therapeutic Vibrator Listing
2027
Clinical Validation & Strategic Pilots
+2028
U.S. Commercial Deployment
*. FDA Class I: 21 CFR 890.5975 - No 510(k) required for immediate market entry.
Partner with Plectrum: Shaping the Future of Remote Care
Join our Clinical Pilot Program (2026) We are inviting leading pediatric OT clinics and rehabilitation centers to integrate Plectrum’s "Active Fabric" technology into their practice. Be at the forefront of the shift from clinic-bound therapy to continuous, data-driven home intervention.
Why Collaborate?
Maximize Practice ROI (Zero CAPEX): Immediate integration with no upfront hardware costs. Capitalize on CPT 97533 to unlock new, high-margin revenue streams per patient.
Expand Your Reach: Treat patients remotely without physical facility constraints.
Objective Data: Replace subjective reports with real-time biometric progress tracking.
Be a Pioneer: Influence the development of adaptive sensory protocols for ASD and SPD.
We're seeking strategic investors to accelerate clinical validation, scale production, and capture the massive $405M Remote Sensory Integration market opportunity. Your investment will fund critical clinical trials, regulatory approvals, and initial market deployment.
Partner with us to pioneer the next frontier of Remote Sensory Integration. Join our mission to bridge the 'Tangibility Gap' and transform therapeutic outcomes for millions worldwide.